Cas:5653-56-5 2,3-dimethoxy-5-methylbenzoic acid manufacturer & supplier

Chemical Name:2,3-dimethoxy-5-methylbenzoic acid

CAS.NO:5653-56-5

Synonyms:2,3-dimethoxy-5-methyl-benzoic acid;2,3-Dimethoxy-5-methyl-benzoesaeure;Benzoic acid,2,3-dimethoxy-5-methyl

Molecular Formula:C₁₀H₁₂O₄

Molecular Weight:196.20000

HS Code:2918990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:55.76000

Exact Mass:196.07400

LogP:1.71040

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,3-dimethoxy-5-methyl-benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid,2,3-dimethoxy-5-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-dimethoxy-5-methyl-benzoic acid Use and application,Benzoic acid,2,3-dimethoxy-5-methyl technical grade,usp/ep/jp grade.

Related News: It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 2,3-dimethoxy-5-methylbenzoic acid manufacturer From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). 2,3-dimethoxy-5-methylbenzoic acid supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 2,3-dimethoxy-5-methylbenzoic acid vendor Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity. 2,3-dimethoxy-5-methylbenzoic acid factory It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.